The EuroHYP-1 trial is a pan-European, open, randomised, phase III clinical trial which will assess the benefit of therapeutic cooling in adult patients with acute ischaemic stroke. In addition to efficacy and safety, the economic impact of therapeutic hypothermia will be also evaluated.
The EuroHYP consortium brings together leading European experts in statistical design and analysis, therapeutic hypothermia, imaging, health economics, ultrasound, biomarkers, and trial execution (implementation and monitoring) as well as European patient and family advocacy groups and Small and Medium-size Enterprises.
European Stroke Conference 2014 in Nice
EuroHYP-1 will be present at the European Stroke Conference in Nice from 6 – 9 May 2014
Come and visit us at stand 302 in the ESC Exhibition area!
More information on the conference: www.eurostroke.eu